Alcon has announced the discontinuation of two of its dry eye products – Bion Tears and Poly Gel. From 1 May, Bion Tears and
Join iCare Consulting Director, Mr Simon Hanna, for this informative webinar as he highlights the current trends and insights from current Medicare usage in
Bayer Australia has announced that Eylea (aflibercept) 8 mg is now registered by the Therapeutic Goods Administration (TGA) for the treatment of neovascular age-related
The South Australian Government has announced a decision to expand the GlassesSA program, as outlined in the SA State Budget 2024–25.
DISCLAIMER : THIS WEBSITE IS INTENDED FOR USE BY HEALTHCARE PROFESSIONALS ONLY.
By agreeing & continuing, you are declaring that you are a registered Healthcare professional with an appropriate registration. In order to view some areas of this website you will need to register and login.
If you are not a Healthcare professional do not continue.
